Androgen receptor (AR) induced precocious myogenesis in culture and myogenic specified gene activity. Increased levels of AR expression in replicating C2C12 myoblasts stimulated fusion into post-differentiated multinucleated myotubes and the appearance of skeletal ␣-actin transcripts, even in the absence of ligand. Furthermore, AR activated the skeletal ␣-actin promoter, which lacks GRE sites, in co-transfected C2C12 cells. AR co-activation of the skeletal ␣-actin promoter required co-expressed full-length serum response factor (SRF). In vitro, AR associated with SRF and was recruited by SRF to a ␣-actin promoter SRF binding site. Our data suggest that AR is capable of activating myogenic genes devoid of consensus AR binding sites via its recruitment by the myogenic enriched transcription factor, SRF.Steroid androgens play an important role in determining lean body mass and muscle strength. For example, men made hypogonadal lose lean body mass and muscle strength (1), whereas in older men, decrements in circulating testosterone levels correlates well with reduced musculature (2). In addition, treatment of hypogonadal men or older men with androgens elicited increased muscle strength and lean body mass (3, 4). Androgens used by healthy young athletes and weightlifters (5) maximize muscle mass and strength. Testosterone increased maximal voluntary strength in a dose-dependent manner (6, 7) and was shown to be a limiting factor in muscle strength development (8), during training-induced muscle hypertrophy (9). Androgens used as a treatment for cachexia also increased fat-free muscle mass and maximum voluntary strength (10). Thus, there is strong evidence that androgens increase muscle mass and strength, both under pathological and physiological conditions.Most studies conducted to date have focused on the positive role of androgens on skeletal muscle protein synthesis (11-13).The molecular basis of myogenic enhancement by androgens is not well understood (6,7,14). The androgen receptor (AR) 1 (15) is a member of the zinc finger class of transcription regulators, and the steroid and thyroid hormone receptor superfamily (16). AR binds androgens by a discrete domain at the 250 C-terminal amino acids of the primary structure (17, 18) and upon binding undergoes phosphorylation (19) and a conformational change. Proteins with the capacity to retain the receptor in the cytoplasm are dissociated and AR nuclear localization signals become exposed allowing for nuclear entry and transcription activation (20). Nuclear hormone receptors are divided in two families, in regard to the DNA sequences they recognize. Estrogen, thyroid, and retinoid acid receptors recognize estrogen response element-like (AGGTCA) sequences, whereas androgen, glucocorticoid, and progesterone receptors recognize GRElike (AGAACA) sequences (21-23). To date, there are no known direct AR DNA targets that drive myogenic specified genes (6). AR, as well as other members of the nuclear receptor superfamily, is modulated by coregulatory proteins (24). Steroid r...